Evidence map›Paper›PMID 35935961›Full record

ArticleFrontiers in immunology2022

Sequence Variations Within

Shingo Suzuki, Satoko Morishima, Makoto Murata, Masafumi Tanaka, Atsuko Shigenari, Sayaka Ito, Uma Kanga, Jerzy K Kulski, Yasuo Morishima, Takashi Shiina

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Shingo SuzukiDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Satoko MorishimaDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Makoto MurataDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masafumi TanakaDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Atsuko ShigenariDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Sayaka ItoDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Uma KangaClinical Immunogenetics Laboratory, Centre for Excellence in Molecular Medicine, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
Jerzy K KulskiDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Yasuo MorishimaDepartment of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan.
Takashi ShiinaDepartment of Molecular Life Science, Tokai University School of Medicine, Isehara, Japan.
Tokai University · JPAichi Medical University · JPAll India Institute of Medical Sciences · INNagoya University · JPUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) is defined as a syndrome of an immunological response of graft to the host that occurs early after allogeneic hematopoietic stem cell transplantation (HCT). This disease is frequently observed even in HCT matched for human leukocyte antigen (HLA) alleles at multiple gene loci. Although the HLA region represents complex and diverse genomic characteristics, detailed association analysis is required for the identification of uncharacterized variants that are strongly associated with aGVHD. We genotyped three loci,

Indexed as

Graft vs Host DiseaseBone Marrow TransplantationGenomicsHistocompatibility Antigens Class IHistocompatibility TestingHLA-G AntigensHumansHistocompatibility Antigens Class IHLA-F antigensHLA-G Antigensbone marrow transplantationgenotypinggraft-versus-host diseasehaplotypehitchhiking diversityhuman leukocyte antigen

Identifiers

PMID35935961
PMCPMC9351719
OpenAlexW4286491050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.